Navigation Links
Johnson & Johnson to Host Pharmaceuticals Business Review
Date:5/19/2011

NEW BRUNSWICK, N.J., May 19, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceuticals business for the investment community beginning at 9:00 a.m. (Eastern Time) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J. ending at approximately 3:00 p.m.

Sheri McCoy, Vice Chairman, Executive Committee, and Pharmaceuticals Worldwide Chairmen Joaquin Duato and Paul Stoffels, M.D. will host the meeting and discuss the role the segment plays in the Company's overall business and growth strategy.  The meeting will also feature presentations from the five therapeutic area leaders in the Pharmaceuticals research and development organization.

Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.  

A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer
2. Johnson & Johnson Holds 2011 Annual Meeting of Shareholders
3. Shareholders to Challenge Johnson & Johnsons Support for Left-Wing Policy Agenda: CEO William C. Weldon to Be Questioned on Firms Failure to Disclose Financial Information on Firms ObamaCare Lobbying It Pledged to Release Last Year
4. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
5. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
6. Johnson & Johnson Reports 2011 First-Quarter Results
7. Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
8. AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)
9. Johnson & Johnson Announces Settlement With U.S. Department of Justice and U.S. Securities and Exchange Commission
10. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
11. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care ... a new PhRMA report on patient out-of-pocket spending: ... Medicare and Medicaid Services (CMS), the average amount spent ... 13% of drug spending in 2016, down from 23% ... a pricing problem, not a coverage problem. Health plans ...
(Date:3/29/2017)... March 29, 2017  Designers of primary cell wearable ... size by 50% and extend battery life with the ... integrated circuit (PMIC) from Maxim Integrated Products, Inc. (NASDAQ: ... low input voltage of just 0.7V for new high-energy ... Oxide, as well as the more common Alkaline battery ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology:
(Date:3/29/2017)... Illinois (PRWEB) , ... March 29, 2017 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... , NetZoom subscribers can request new equipment shapes for free and download shapes ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... Richmond, VA (PRWEB) , ... March 29, 2017 , ... ... of its seventh North American office location in Richmond, Virginia, located at the Riverfront ... April 11, attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is the first technology to directly address the resolution to globally reduce the ... is a patented compound of FDA and TTB approved ingredients that when infused ...
(Date:3/28/2017)... ... 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid ... Thyroid Secret. Dr. Wentz talked about journey and research recently on a blog and ... NOT the only solution to deal with thyroid disease. , Dr. Wentz completed ...
Breaking Medicine News(10 mins):